435 related articles for article (PubMed ID: 31768599)
21. Deep learning signature of brain [
Ryoo HG; Byun JI; Choi H; Jung KY
Sci Rep; 2022 Nov; 12(1):19259. PubMed ID: 36357491
[TBL] [Abstract][Full Text] [Related]
22. Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.
Fan Z; Aman Y; Ahmed I; Chetelat G; Landeau B; Ray Chaudhuri K; Brooks DJ; Edison P
Alzheimers Dement; 2015 Jun; 11(6):608-21.e7. PubMed ID: 25239737
[TBL] [Abstract][Full Text] [Related]
23. Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study.
Teng L; Li Y; Zhao Y; Hu T; Zhang Z; Yao Z; Hu B;
BMC Neurol; 2020 Apr; 20(1):148. PubMed ID: 32316912
[TBL] [Abstract][Full Text] [Related]
24. FDG-PET as an independent biomarker for Alzheimer's biological diagnosis: a longitudinal study.
Ou YN; Xu W; Li JQ; Guo Y; Cui M; Chen KL; Huang YY; Dong Q; Tan L; Yu JT;
Alzheimers Res Ther; 2019 Jun; 11(1):57. PubMed ID: 31253185
[TBL] [Abstract][Full Text] [Related]
25. MRI or
Doering E; Antonopoulos G; Hoenig M; van Eimeren T; Daamen M; Boecker H; Jessen F; Düzel E; Eickhoff S; Patil K; Drzezga A;
J Nucl Med; 2024 Jan; 65(1):147-155. PubMed ID: 38050112
[TBL] [Abstract][Full Text] [Related]
26. Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment.
Apostolova I; Lange C; Suppa P; Spies L; Klutmann S; Adam G; Grothe MJ; Buchert R;
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1417-1422. PubMed ID: 29502311
[TBL] [Abstract][Full Text] [Related]
27. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
Nobili F; Arbizu J; Bouwman F; Drzezga A; Agosta F; Nestor P; Walker Z; Boccardi M;
Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
[TBL] [Abstract][Full Text] [Related]
28. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
[TBL] [Abstract][Full Text] [Related]
29. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
Wu L; Liu FT; Ge JJ; Zhao J; Tang YL; Yu WB; Yu H; Anderson T; Zuo CT; Chen L; Wang J
Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
[TBL] [Abstract][Full Text] [Related]
31. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
Garcia-Garcia D; Clavero P; Gasca Salas C; Lamet I; Arbizu J; Gonzalez-Redondo R; Obeso JA; Rodriguez-Oroz MC
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1767-77. PubMed ID: 22872307
[TBL] [Abstract][Full Text] [Related]
32. Deep Learning for Alzheimer's Disease Classification using Texture Features.
So JH; Madusanka N; Choi HK; Choi BK; Park HG
Curr Med Imaging Rev; 2019; 15(7):689-698. PubMed ID: 32008517
[TBL] [Abstract][Full Text] [Related]
33. Visual Rating and Computer-Assisted Analysis of FDG PET in the Prediction of Conversion to Alzheimer's Disease in Mild Cognitive Impairment.
Kang JM; Lee JY; Kim YK; Sohn BK; Byun MS; Choi JE; Son SK; Im HJ; Lee JH; Ryu YH; Lee DY
Mol Diagn Ther; 2018 Aug; 22(4):475-483. PubMed ID: 29761365
[TBL] [Abstract][Full Text] [Related]
34. A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using
Ding Y; Sohn JH; Kawczynski MG; Trivedi H; Harnish R; Jenkins NW; Lituiev D; Copeland TP; Aboian MS; Mari Aparici C; Behr SC; Flavell RR; Huang SY; Zalocusky KA; Nardo L; Seo Y; Hawkins RA; Hernandez Pampaloni M; Hadley D; Franc BL
Radiology; 2019 Feb; 290(2):456-464. PubMed ID: 30398430
[TBL] [Abstract][Full Text] [Related]
35. Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptoms.
Arvidsson I; Strandberg O; Palmqvist S; Stomrud E; Cullen N; Janelidze S; Tideman P; Heyden A; Åström K; Hansson O; Mattsson-Carlgren N
Alzheimers Res Ther; 2024 Mar; 16(1):61. PubMed ID: 38504336
[TBL] [Abstract][Full Text] [Related]
36. 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.
Smailagic N; Lafortune L; Kelly S; Hyde C; Brayne C
J Alzheimers Dis; 2018; 64(4):1175-1194. PubMed ID: 30010119
[TBL] [Abstract][Full Text] [Related]
37. Ensembles of Deep Learning Architectures for the Early Diagnosis of the Alzheimer's Disease.
Ortiz A; Munilla J; Górriz JM; Ramírez J
Int J Neural Syst; 2016 Nov; 26(7):1650025. PubMed ID: 27478060
[TBL] [Abstract][Full Text] [Related]
38. Visual assessment versus quantitative three-dimensional stereotactic surface projection fluorodeoxyglucose positron emission tomography for detection of mild cognitive impairment and Alzheimer disease.
Lehman VT; Carter RE; Claassen DO; Murphy RC; Lowe V; Petersen RC; Peller PJ
Clin Nucl Med; 2012 Aug; 37(8):721-6. PubMed ID: 22785496
[TBL] [Abstract][Full Text] [Related]
39. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
J Alzheimers Dis; 2018; 62(1):399-408. PubMed ID: 29439345
[TBL] [Abstract][Full Text] [Related]
40. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
